Spectral-Domain Optical Coherence Tomography-Driven Treat-and-Extend and Pro Re Nata Regimen in Patients with Macular Oedema due to Retinal Vein Occlusion: 24-Month Evaluation and Outcome Predictors | Zendy

Maria-Magdalena Guichard | Zendy; Anton R. Xavier | Zendy; Cengiz Türksever | Zendy; Christian Pruente | Zendy; Katja Hatz | Zendy

Open Access

Spectral-Domain Optical Coherence Tomography-Driven Treat-and-Extend and Pro Re Nata Regimen in Patients with Macular Oedema due to Retinal Vein Occlusion: 24-Month Evaluation and Outcome Predictors

Author(s) -

Maria-Magdalena Guichard,

Anton R. Xavier,

Cengiz Türksever,

Christian Pruente,

Katja Hatz

Publication year - 2018

Publication title -

ophthalmic research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.893

H-Index - 54

eISSN - 1423-0259

pISSN - 0030-3747

DOI - 10.1159/000487489

Subject(s) - pro re nata , medicine , ophthalmology , retinal , ranibizumab , visual acuity , branch retinal vein occlusion , macular edema , nuclear medicine , bevacizumab , chemotherapy

To analyse the efficacy and outcome predictors of ranibizumab using a spectral-domain optical coherence tomography (SD-OCT)-driven treat-and-extend regimen (TER) versus SD-OCT-driven pro re nata regimen (PRN) in patients with cystoid macular oedema (CME) due to branch or central retinal vein occlusion (BRVO, CRVO).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research